This inventor holds 9 USPTO granted patents, plus 2 CIPO patents. Top assignee: Merck + Co., Inc.. Active years: 1995-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-2003
Title: The Innovations of Michael J Kaufman
Introduction
Michael J Kaufman is a prominent inventor based in New Hope, PA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 9 patents. His work focuses on enhancing cognition and developing treatments for various medical conditions.
Latest Patents
Among his latest patents are therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations. These patents disclose a compound known as 3-(5-methylisoxazol-3-yl)-6-(1-methyl-1,2,3-triazol-4-yl)methyloxy-1,2,4-triazolo[3,4-a]phthalazine in various hydrated forms. The pharmaceutical compositions derived from these forms are aimed at enhancing cognitive function. Additionally, he has developed a salt form of a conjugate that is useful in the treatment of prostate cancer.
Career Highlights
Michael J Kaufman is currently employed at Merck & Company, Inc., where he continues to innovate and contribute to the pharmaceutical industry. His extensive research and development efforts have led to advancements in drug formulations and therapeutic applications.
Collaborations
Throughout his career, Kaufman has collaborated with notable colleagues, including David C Dubost and William A Hunke. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Michael J Kaufman is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in cognitive enhancement and cancer treatment. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile